CymitQuimica logo

CAS 915087-33-1

:

Enzalutamide

Description:
Enzalutamide is a non-steroidal anti-androgen medication primarily used in the treatment of prostate cancer. It functions by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and proliferation of prostate cancer cells. The chemical formula of enzalutamide is C21H16F4N4O2, and it features a complex structure that includes a biphenyl moiety and a hydantoin ring. Enzalutamide is characterized by its high affinity for the androgen receptor, effectively blocking the action of androgens like testosterone and dihydrotestosterone. This compound is typically administered orally and is known for its favorable pharmacokinetic profile, including good bioavailability and a long half-life, allowing for once-daily dosing. Common side effects may include fatigue, hot flashes, and hypertension. Enzalutamide has been shown to improve overall survival in patients with metastatic castration-resistant prostate cancer, making it a significant therapeutic option in oncology. Its development represents a critical advancement in targeted cancer therapies, particularly in hormone-sensitive malignancies.
Formula:C21H16F4N4O2S
InChI:InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)
InChI key:InChIKey=WXCXUHSOUPDCQV-UHFFFAOYSA-N
SMILES:S=C1N(C(C)(C)C(=O)N1C2=CC(C(F)(F)F)=C(C#N)C=C2)C3=CC(F)=C(C(NC)=O)C=C3
Synonyms:
  • 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide
  • Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-
  • Enzalutamide
  • Mdv 3100
  • Mdv3100
  • S-Enzalutamide
  • Xtandi
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 15 products.